Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069314
Filing Date
2025-05-12
Accepted
2025-05-12 16:34:55
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q catx-20250331.htm   iXBRL 10-Q 1771679
2 EX-31.1 catx-ex31_1.htm EX-31.1 16378
3 EX-31.2 catx-ex31_2.htm EX-31.2 16362
4 EX-32 catx-ex32.htm EX-32 12337
  Complete submission text file 0000950170-25-069314.txt   8367890

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20250331.xsd EX-101.SCH 1392131
72 EXTRACTED XBRL INSTANCE DOCUMENT catx-20250331_htm.xml XML 1434222
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33407 | Film No.: 25935436
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)